| Code | CSB-RA619965MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is developed as a research-grade biosimilar to Ibentatug, targeting plectin (PLEC), a large cytolinker protein that plays a crucial role in maintaining cellular structural integrity. PLEC functions as a versatile scaffolding molecule that connects intermediate filaments to other cytoskeletal elements, hemidesmosomes, and organelles, thereby ensuring mechanical stability and signal transduction in various cell types. Mutations in PLEC are associated with epidermolysis bullosa simplex with muscular dystrophy, while altered plectin expression has been implicated in cancer progression, invasion, and metastasis across multiple tumor types.
Ibentatug represents a therapeutic antibody that has been investigated for its potential in targeting plectin-expressing cells. This biosimilar antibody provides researchers with a valuable tool for investigating plectin's roles in cytoskeletal organization, cell adhesion, tissue integrity, and disease pathogenesis. It enables studies examining plectin's involvement in cancer biology, neuromuscular disorders, and cellular mechanotransduction pathways, supporting advances in understanding both normal cellular function and disease mechanisms.
There are currently no reviews for this product.